systemic lupus erythematosus

Open Access
Adjuvant Molecular Hydrogen Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report on Immunomodulatory Effects on Regulatory and Effector Lymphocytes
CHIN LIU, JENG-WEI LU, CHUN-HSIEN WU, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG and FENG-CHENG LIU

In Vivo January 2026, 40 (1) 551-560; DOI: https://doi.org/10.21873/invivo.14220
Open Access
Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report
HAN-LUEN TSAI, JENG-WEI LU, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG and FENG-CHENG LIU

In Vivo January 2026, 40 (1) 561-570; DOI: https://doi.org/10.21873/invivo.14221
Open Access
Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report
CHIN LIU, JENG-WEI LU, CHUN-HSIEN WU, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG and FENG-CHENG LIU

In Vivo November 2025, 39 (6) 3656-3664; DOI: https://doi.org/10.21873/invivo.14165
Open Access
Immunomodulatory Effects of Molecular Hydrogen Therapy in Systemic Lupus Erythematosus With Pericarditis and Pleuritis: A Case Report
TING-HAO TU, JENG-WEI LU, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG and FENG-CHENG LIU

In Vivo September 2025, 39 (5) 3014-3024; DOI: https://doi.org/10.21873/invivo.14103
Open Access
Infective Endocarditis and Valve Surgery in a Systemic Lupus Erythematosus Patient Following Splenectomy: A Case Report with Immunological Analysis
CHIN LIU, JENG-WEI LU, HSIAO-CHEN LIU, YI-JUNG HO, KUANG-YIH WANG and FENG-CHENG LIU

In Vivo September 2025, 39 (5) 3025-3036; DOI: https://doi.org/10.21873/invivo.14104
Open Access
Molecular Hydrogen as an Adjuvant Therapy in Comorbid Sjögren’s Syndrome, SLE, and ILD: A Case Report on Immune Modulation and Fatigue Reduction
YING-HSUAN TSAI, JENG-WEI LU, JOU-I TU, YUAN-JU LI, HUI-FU HSU, FENG-HAO CHANG, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG and FENG-CHENG LIU

In Vivo July 2025, 39 (4) 2228-2235; DOI: https://doi.org/10.21873/invivo.14018
Open Access
A Case of Seronegative Lupus Nephritis Detected Incidentally by Renal Biopsy
AKIRA MIMA, TAKAMASA MATSUKI, TAKAHIRO NAKAMOTO, YUTA SAITO, TAKAAKI MORIKAWA, SAKURA KURE, KEISHI MATSUMOTO and SHINJI LEE

In Vivo July 2025, 39 (4) 2328-2332; DOI: https://doi.org/10.21873/invivo.14029
Open Access
Molecular Hydrogen as an Adjuvant Therapy in Severe Lupus Serositis With Heart Failure: A Case Report on Immune Modulation and Fatigue Reduction
YUN-TING LIN, JENG-WEI LU, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, HSIAO-CHEN LIU, KUANG-YIH WANG and FENG-CHENG LIU

In Vivo March 2025, 39 (2) 1200-1206; DOI: https://doi.org/10.21873/invivo.13924
Open Access
Molecular Hydrogen Therapy for SLE-PAH: Case Report on Immune Marker Modulation
TING-HAO TU, JENG-WEI LU, CHUN-HSIEN WU, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG and FENG-CHENG LIU

In Vivo March 2025, 39 (2) 1211-1219; DOI: https://doi.org/10.21873/invivo.13926
Open Access
Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells
JING-YUAN CHEN, JENG-WEI LU, SHAO-WEI FENG, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH and FENG-CHENG LIU

In Vivo November 2024, 38 (6) 3131-3137; DOI: https://doi.org/10.21873/invivo.13799

Main menu

User menu

Search

systemic lupus erythematosus

Pages